Dated 21st October 2002 OXFORD IMMUNOTEC GLOBAL PLC (1) and DR P WRIGHTON-SMITH (2) SERVICE AGREEMENTService Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
REGISTRATION RIGHTS AGREEMENT dated 21 November, 2013 by and among Oxford Immunotec Global PLC and certain shareholdersRegistration Rights Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
SECOND AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
THIS SECOND AMENDMENT TO SUPPLY AGREEMENT (“Second Amendment”) is made and entered into as of the 25 day of March 2014 (“Effective Date”) by and between EMD Millipore Corporation, (“Millipore”) and Oxford Immunotec, Ltd. (“Oxford”).
ContractWarrant Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS, AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 4 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
ContractWarrant Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • England and Wales
THIS WARRANT AND THE SHARES PURCHASABLE HEREUNDER HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
Dated and AssignmentAssignment • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
